Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.
Also called NCT02113332
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 124 participants
- Registry
-
NCT02113332 -
2012-001941-42
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Sweden
- Registry status
- Completed
Technical summary
Registry record NCT02113332. Randomized; quadruple masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2014-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Liraglutide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Vastra Gotaland Region
- Collaborator
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct02113332- Content hash
abfe8bccd56d79463ab89ef826b0ab72454021fc9d9377debe2eea5dadf7ceec